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Crystal structure of the DNA-
binding domain of Myelin-gene 
Regulatory Factor
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Myelin-gene Regulatory Factor (MyRF) is one of the master transcription factors controlling myelin 
formation and development in oligodendrocytes which is crucial for the powerful brain functions. The 
N-terminal of MyRF, which contains a proline-rich region and a DNA binding domain (DBD), is auto-
cleaved from the ER membrane, and then enters the nucleus to participate in transcription regulation of 
the myelin genes. Here we report the crystal structure of MyRF DBD. It shows an Ig-fold like architecture 
which consists of two antiparallel β-sheets with 7 main strands, packing against each other, forming a 
β-sandwich. Compared to its homolog, Ndt80, MyRF has a smaller and less complex DBD lacking the 
helices and the big loops outside the core. Structural alignment reveals that MyRF DBD possess less 
interaction sites with DNA than Ndt80 and may bind only at the major groove of DNA. Moreover, the 
structure reveals a trimeric assembly, agreeing with the previous report that MyRF DBD functions as 
a trimer. The mutant that we designed based on the structure disturbed trimer formation, but didn’t 
affect the auto-cleavage reaction. It demonstrates that the activation of self-cleavage reaction of MyRF 
is independent of the presence of its N-terminal DBD homotrimer. The structure reported here will help 
to understand the molecular mechanism underlying the important roles of MyRF in myelin formation 
and development.
Myelin-gene Regulatory Factor (MyRF, also known as MRF, Gm98 or C11Orf9 in human) is considered one of 
the master transcription factors for myelin production by oligodendrocytes in the central nervous system, which 
permits action potentials to propagate by saltatory conduction along axons and is very important for powerful 
brain functions. MyRF is only expressed on the terminal differentiation of oligodendrocytes and controls mye-
lin gene expression directly. When MyRF is deleted, the expression of many myelin related proteins cannot be 
detected1. Loss of myelin results in many severe diseases such as multiple sclerosis2, leukodystrophies3 and defect 
in motor learning capability4.
MyRF was revealed as a transmembrane (TM) protein located at the endoplasmic reticulum (ER) membrane5. 
Its cytoplasmic portion contains an N-terminal proline-rich region and a following DNA binding domain (DBD) 
which can be auto-cleaved from the ER membrane by a region between the DNA-binding and TM domains. 
This region is homologous to bacteriophage tailspike proteins and is named ICA (Intramolecular Chaperone 
Auto-processing)6 or ICD (intramolecular chaperone domain)7 which has been found in eukaryotic proteins 
for the first time. Overexpressed MyRF possess a smaller molecular weight than calculated due to auto-cleavage. 
It is not clear whether the auto-cleavage mechanism of MyRF is the same as observed for the tailpike protein in 
the maturation of bacteriophage endosialidases8. After cleavage, the N-terminal part of MyRF releases from the 
ER membrane and enters the cell nucleus guided by the NLS signal within its sequence to activate myelin gene 
expression. The C-terminal cleavage product of MyRF remains on the ER membrane and its function remains 
elusive. It is clear that MyRF is a membrane-bound transcription factor (MBTF) cleaved with the novel bacterio-
phage tailspike-like self-cleavage mechanism6, 7, 9.
The DBD of MyRF is the main focus for its transcriptional regulation function. It was predicted to be an Ig-fold 
transcription factor and is homologous to the yeast sporulation-specific transcription factor Ndt80. However, the 
size of MyRF DBD is more close to the typical Ig-fold transcription factors while Ndt80 was found to be more 
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complex and showing more extensive contacts with DNA. Thus, the interaction of MyRF DBD with DNA may 
be different from Ndt80. Moreover, previous reports showed that MyRF DBD functions as a trimer6, while Ndt80 
binds with DNA as a monomer10. Recently bioinformatic studies revealed the preferential DNA binding target of 
MyRF DBD7, which is very different from the Ndt80 target sequence. Thus their DNA binding properties ought 
to be different too. The details of the interaction between MyRF and its target DNA still need to be investigated. 
Further studies will also help to understand the molecular mechanism of MyRF co-operating with other tran-
scription factors such as Sox10 and Olig2 during oligodendrocyte development and myelin formation11, 12.
In this report, we solved the crystal structure of MyRF DBD and demonstrate that it forms a trimer in the 
crystal lattice. Unlike Ndt80, MyRF DBD may only interact with the major groove of target DNA. The mutations 
designed based on our structure disrupted trimer formation but had no effect on auto-cleavage. Our data will help 
to understand the detailed molecular mechanism of myelin gene transcriptional regulation.
Results and Discussion
Overall structure of MyRF DBD. The expressed MyRF fragment (351–717 plus N-terminal his tag and 
linker) showed a smaller molecular weight than calculated (33 vs. 45 kDa) due to auto-cleavage, which matches 
with the previous reports6, 7. Using limited proteolysis, we generated a proteolytically resistant DBD core that is 
about 24kD. This DBD core was purified and crystallized.
Figure 1. Structure of the MyRF DNA binding domain (DBD). All the strands are labeled according to their 
occurrence in the primary sequence and the standard nomenclature of Ig- fold13. (A) Overview of MyRF DBD 
structure (351–532). The strands and loop are colored yellow and green respectively. (B) Topology diagram of 
MyRF DBD. The conserved s-type Ig-fold strands are indicated in black, while the peripheral outer strands, in 
gray. (C) Secondary structure and sequence alignment of MyRF DBD. Mouse MyRF is aligned with sequences 
from other vertebrate (human, frog and fish), nematode (PQN47) and Dictyostelium (mrfA). The residue 
numbering along the top refers to the mouse MyRF.
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The structure was determined for the selenomethionyl substituted crystals by using single anomalous dif-
fraction (SAD) phasing from 4 ordered Se atoms per molecule of 210 residues (see Materials and Methods). The 
resulting experimental electron density map calculated was of sufficient quality to build an initial chain trace 
and assign the amino acid residues. The structural model has been completed and refined to 2.46 Å resolution 
(Rwork = 18% and Rfree = 23%). The space group is P321 (104.0, 104.0, 46.7, 90, 90, 120), with one molecule per 
asymmetric unit. Of the 210 amino acids corresponding to the DBD, only residues 351–532 were clearly visible 
in the electron density map (Fig. 1A).
MyRF DBD is highly conserved in vertebrates (Fig. 1C) and its structure shows a typical Ig-fold architecture. 
The main part of MyRF DBD consists of two antiparallel β-sheets that have three strands (a, b and e) and five 
strands (c’, c, f, g and β1) respectively, labeled according to the standard nomenclature of Ig-fold13. MyRF DBD 
can be classified as an s-type Ig-fold, although the 4th switched strand c’ is not obvious. Instead, the N-terminal 
β1 strand is located next to the g strand of the c–f–g β-sheet, as observed in Ndt80. The sheets pack against each 
other, forming a β-sandwich with a “Greek key” topology (Fig. 1B). At the end of the β-sandwich, the sheets pack 
tightly, forming a compact barrel-like structure (Fig. 1A). In addition, there are nine outer strands between the 
core strands, which are numbered according to their occurrence in the primary sequence. Each group of 3 of 
these outer strands forms a sheet at the end of core β-barrel. The ribbon representation of the DBD and its topol-
ogy are illustrated in Fig. 1A and B, respectively.
Generally, Ig-fold proteins do not display high identity to one another at the primary sequence level, although 
they are similar in their 3D architecture. Consistent with this, MyRF DBD sequence does not show high homol-
ogy with other members of Ig-fold family, but the structures with similar topology are found in the Protein 
Structure Database.
Comparison with other Ig-fold transcription factors. MyRF DBD is similar in topology to the Ndt80 
transcription factors (Fig. 2), as demonstrated by being the best match in a DALI search14 with an root mean 
square deviation (RMSD) of 2.1 Å for 162 Cα atoms and 16% sequence identity. Although MyRF DBD and the 
core of the Ndt80 can be well aligned with each other, Ndt80 is significantly larger than MyRF DBD and other 
Ig-fold transcription factors. MyRF DBD mainly consists of β-strands. No helical segment and big loop between 
the core strands are observed, which makes it smaller and less complex than Ndt80. In Ig-fold proteins, the outer 
strands in the sheets, and the loops between the core strands in particular, are flexible and can be relocated in 
different proteins without perturbing the core structure of Ig-fold. Without the N-terminal β-hairpin-loop- helix 
insert, the helix–loop–helix inserts in the c’–e loop, the helix in the C terminal and the helix in the c–c’ loop 
(which are involved in the direct interaction with target DNA and form an essential sequence-specific recognition 
site for Ndt80 interacting with target DNA), the interaction of MyRF DBD with target DNA should be different 
than the one of Ndt80. The fact that MyRF shows less contact with target DNA than Ndt80 indicated that it may 
bind DNA as a multimer or cooperate with other transcription factors to fulfil its myelin gene activation function.
The second best match of the Ig-like transcription factors in the DALI search was with the members of p5315, 
16 family, resulting in an RMSD of 2.9 Å for 112 Cα atoms and 13% sequence identity. Although the core strands of 
p53 are shorter than MyRF DBD, 7 core strands of them can be aligned together while the outer strands between 
the core strands are different. Their DNA binding sites also are different. The other transcription factors resulting 
from the DALI search showing high degree of structural homology to MyRF DBD include members of STAT17, 
Runx18. Some other Ig-fold proteins, such as the Cholesterol-binding Protein19, 20, ATP binding part of ABC 
Transporter21 and sugar-binding domain of β-galactosidase22, have even higher score in the DALI search than 
p53, STAT and Runx, but they do not belong to the transcription factor family.
Figure 2. The superimposed structures of MyRF DBD and Ndt80 (PDB code: 1MNN) colored in ice blue and 
gold respectively. The figure was generated using CCP4gm software.
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Oligomization of MyRF DBD. MyRF DBD forms a trimer with a crystallographic three-fold symmetry axis in 
the crystal (Fig. 3A–D). The trimer interface buries a 1497.6 Å2 surface area, accounting for 14.5% of total mono-
mer surface area (http://pdbe.org/pisa/). The trimer interaction is mainly mediated by 2 contact regions. Residues 
438–442 of the loop between strand c and β7 from one protomer form 3 hydrogen bond interactions with resi-
dues 469–471 of strand e from the neighboring protomer. Residues 354–360 of the loop between strand β1 and 
β2 from one protomer form 4 hydrogen bond interactions with residues 371–377 of the loop before strand a from 
the other protomer (Fig. 3E). In addition, Arg378 and Lys473 in one of the protomers are positioned in close 
proximity to E525 and D392 in the other protomer respectively, creating electrostatic attraction that strengthens 
the trimer formation.
Figure 3. Oligomerization of MyRF DBD in crystal. (A) Crystal packing of MyRF DBD viewed from the c 
axis. Unit cell is shown in black lines. (B) Side view of crystal packing. (C) Cartoon diagram of MyRF DBD 
trimer (crystallographic symmetry-related protomers) (D) Side view of MyRF DBD trimer. (E) Stereo view of 
detailed trimeric interactions between 2 neighboring protomers. The residues involved in the hydrogen bond 
interactions are shown with a stick model; nitrogen and oxygen atoms are colored blue and red respectively. 2 
neighboring protomers are illustrated and colored ice blue and gold respectively.
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The PISA program predicts that MyRF DBD forms a metastable trimer. The molecular weight of MyRF 
DBD after auto-cleavage (351–586 plus N-terminal his tag and linker) is similar to the N-terminal fragment 
(StrepII-MyRF-319:577) reported6. All monomers run at a similar position on SDS-PAGE (Fig. 4A, lane 3). On 
gel filtration, MyRF DBD eluted as a single peak corresponding to a trimer (Fig. 4B, blue peak). Moreover, even 
the proteolytically resistant MyRF DBD core only (after treated by limited proteolysis of trypsin) still maintains 
as a trimer (Fig. 4B, cyan peak).
Previous studies have shown that full-length MyRF forms a trimer before cleavage. The ICA domain 
was thought to play the main role in MyRF trimer formation due to its C-terminal trimeric helix bundle. It 
is known that trimerization is required for the auto-cleavage reaction in ICA containing phage tailspike pro-
teins8. Our structure indicates the N terminus of MyRF (which contains the proline-rich and DBD region only) 
after auto-cleavage can still keep the trimeric architecture, in agreement with previous results6. As observed in 
the trimer structure of MyRF DBD, the residues 469–471 and 438–442 lie on the trimer interfaces and form 3 
hydrogen bonds between protomers. Based on this structural information, the site-directed mutant MyRF DBD 
E469R&439-441del was designed. The result of size exclusion chromatography showed that E469R&439-441del 
mutant disturbed the trimer formation (Fig. 4B, red peak). The crystal structure of bacteriophage K1F endosiali-
dase tailspike protein shows its ICA domain and endosialidases upstream are connected by a triple β-helix. In this 
triple β-helix, three polypeptide chains wind around a common threefold symmetry axis. Proper assembly of this 
triple–β-helical fold depends on the trimeric helix bundle on the ICA C-terminal. The cleavage reaction of ICA 
acts as a control mechanism for generating a correctly folded protein. Only if endosialidases domain upstream 
Figure 4. MyRF DBD mutation disturbs trimer formation but does not affect auto-cleavage of MyRF. (A) 
The auto-cleavage of MyRF and its mutants were analyzed by 12% SDS-PAGE. M: protein marker. (B) Elution 
profiles from gel filtration chromatography of MyRF DBD and its mutant. Calibration curve of proteins with 
known molecular weights (ferritin (443 kDa), bovine serum albumin (BSA; 66 kDa), chicken ovalbumin 
(44kD); Sigma-Aldrich) was shown. The molecular weight of these proteins was plotted against their calculated 
Ve/Vo and fitted by exponential regression analysis. On the basis of the calculation, the Ve/Vo of wild type 
MyRF DBD results in a molecular weight of 110 kDa, and the Ve/Vo of its mutant results in a molecular weight 
of 35 kDa, indicating the trimeric and the monomeric form of protein respectively. The Ve/Vo of wild type 
MyRF DBD core only (after treated by limited proteolysis of trypsin) results in a molecular weight of 70 kDa, 
indicating the trimeric form too.
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of triple β-helix folds to a proper trimer, and the side chains of the key residues involved are in the right position, 
the self-cleavage reaction can occur8. Surprisingly, the mutation E469R&441-443del in MyRF did not affect its 
self-proteolytic processing, although the mutation disturbed the formation of MyRF DBD trimer (Fig. 4A, lane 
2). It demonstrates that the activation of self-cleavage of MyRF is independent of its N terminal DBD trimer. 
The proper assembly of the triple–β-helical fold of MyRF, which depends on the ICA and its C-terminal trimeric 
helix bundle, triggers a serine-lysine catalytic dyad to activate the self-proteolysis. Consistent with this, the DBD 
of MrfA (the ortholog of MyRF in Dictyostelium) is separated from the triple β-helix of ICA domain by a large 
disordered fragment, resulting in the difficult to affect each other. The mutants in the trimeric helix bundle of ICA 
C-terminal, which disturb the trimer assembly, prevented the self-cleavage of MyRF6. The control mechanism of 
self-cleavage reaction of MyRF and its relationship with generating a correctly folded trimeric MyRF DBD still 
need to be investigated.
Predicted DNA binding. The electrostatic surface potential measurement of MyRF DBD structure reveals a 
highly electropositive surface owing to the presence of lysine and arginine residues at the bottom of the β-barrel 
core (Fig. 5A). Superposition of MyRF DBD and Ndt80 showed that these residues may be involved in the inter-
action of the protein with DNA (Fig. 5B). In particular, 3 conserved alkaline residues in MyRF (K399, R454 and 
R478) are superimposable with the residues of Ndt80 (R111, R177 and R254) interacting at the major groove of 
DNA, implying that they may be involved in interaction with DNA too (Fig. 5B). The individual point mutants of 
these residues dramatically decreased MyRF DNA binding capacity7, 23. The aligned structures show that MyRF 
DBD may only have 4 binding sites, while Ndt80 possess 6 binding sites with the target DNA. The 2 extra binding 
sites of Ndt80 are located at the minor groove of DNA and come from the extra N terminal β-hairpin-loop-helix 
and helix–loop–helix inserts in the c’– e loop. All of other 4 binding sites are located at the major groove of DNA. 
The comparison of their structures indicates that the MyRF DBD monomers have lower binding affinity to DNA 
than Ndt80. Their differences in binding residues and the position suggest they may recognize different target 
DNA sequences.
Trimer-DNA binding. MrfA, the ortholog of MyRF in Dictyostelium was reported to bind DNA via three dis-
tinct elements with 3–5 bp spacing. Mutagenesis studies showed that all three elements are needed for optimal 
expression in vivo23. Previous studies also suggested that MyRF is functional as a trimer6, 7, though some of MyRF 
binding sites identified by ChIP-Seq only had a single binding motif7. Consistent with these results, our crystal 
structure shows MyRF DBD tends to assemble into a homo-trimer. The fact that the promoters of target genes 
contain different number of the MyRF binding motifs suggests that different genes may be regulated differently. 
How this trimer interacts with three elements of target DNA is still unclear. According to the model of a sin-
gle MyRF DBD interacting with DNA, the DNA molecule should bind at the bottom of a trimer. However, it 
seems difficult to arrange three DNA elements on 3 protomers of a trimer simultaneously with 3–5 bp spac-
ing only (Fig. 5C). Generally, transcription factors interact with DNA as monomers, dimers or tetramers while 
homo-trimeric transcription factors are rare. Well characterized homo-trimeric transcription factors are heat 
shock factor 124 and ArgR25. Their DBDs do not form trimers directly, but are connected to a trimeric domain by 
a flexible linker thereby being able to bind on 2 or 3 tandem and adjacent elements at the same time. MyRF is the 
first transcription factor discovered so far in which the DBD forms a homo-trimer by itself. The relative position 
of the protomer’s DNA binding sites does not allow major structural changes, otherwise, the MyRF DBD trimer 
Figure 5. The electrostatic surface of MyRF DBD and the superposition of MyRF DBD with Ndt80 shows 
potential DNA binding region. (A) The electrostatic surface potential of MyRF DBD shows the electropositive 
region for potential DNA binding. The NH2- (N) and the –COOH (C) terminus of MyRF DBD are marked. 
(B) Superposition of MyRF DBD and Ndt80 shows the region that may be involved in the interaction between 
MyRF DBD and its target DNA. The residues K399, R454, R478 (MyRF) and R111, R177, R254 (Ndt80) are 
shown as a sphere model. MyRF DBD and Ndt80 colored in ice blue and gold respectively. (C) The modeling of 
MyRF DBD trimer binding with its target DNA. The DNA molecules are shown as a sphere model.
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would disassemble. How MyRF activates the expression of its target genes in a trimeric manner is still unclear and 
further studies are required.
MyRF may cooperate with other transcription factors to control myelin gene expression in oligodendrocytes. 
It induces a cohort of genes that work together to wrap axon myelin sheathes in the central nervous system. Our 
structure shows that the N-terminus of MyRF DBD is located at the bottom of the β-barrel core and close to its 
DNA binding sites (Fig. 5A). Thus the N-terminal proline-rich region, located before the DBD of MyRF, may 
interact with other transcriptional factors directly. The MyRF homo-trimer can either be stabilized or destabilized 
by these interactions to regulate the myelin genes expression.
In conclusion, we presented a high resolution structure of MyRF DBD protein with an Ig-fold architecture which 
consists of two antiparallel β-sheets with 7 main strands, packing against each other, forming a β-sandwich. The 
structure of MyRF DBD is similar to the core of Ndt80, but with less interaction sites and a different DNA recogni-
tion sequence. The structure reveals that MyRF DBD forms a trimer, in agreement with the previous reports demon-
strating that MyRF DBD is functional as a trimer. The mutant designed based on the structure demonstrates that the 
activation of self-cleavage of MyRF is independent of its N terminal DBD trimer. The electrostatic surface potential 
analysis and comparison with the structure of the complex of Ndt80 and DNA reveal the possible interaction sites 
between MyRF DBD and DNA, thereby providing molecular mechanistic insight into its transcriptional regulation.
Methods
Expression plasmids. Mouse MyRF DNA fragment (residues 351–717, containing DBD and ICA) was 
amplified from a full length gene clone (NP_001028653.1) and sub-cloned into the modified pRSFDuet-1 vec-
tor (Novagen) with an N-terminal 6xHis tag and a flexible linker. Point mutations were introduced using the 
QuikChange protocol (Stratagene). All constructs were confirmed by DNA Sanger sequencing.
Protein expression and Purification. The recombinant MyRF was obtained by expression in Escherichia 






 a, b, c (Å) 104.0 104.0 46.7
 α, β, γ (°) 90.0 90.0 120.0




Completeness (%) 99.76 (98.31)
Redundancy 10.6 (10.1)
Refinement
Resolution (Å) 34.03 – 2.46









 Bond lengths (Å) 0.010
 Bond angles (°) 1.210
Ramachandran plot
Favored regions (%) 97
Allowed refions (%) 3
Outliers (%) 0
Table 1. Data collection and refinement statistics. *Values in parentheses are statistics for highest resolution 
shell. aRmerge = Σhkl ΣI|Ii(hkl) − < I(hkl) > | ΣhklΣiIi (hkl), where Ii(hkl) is the intensity of the ith measurement 
of reflection hkl, i™ncluding symmetry-related reflections, and < I(hkl) > is their average. bI /σ(I) = mean of 
intensity/σ(I) of unique reflections (after merging symmetry-related observations), σ(I) = standard deviation of 
reflection intensity I estimated from sample statistics. cRwork = ΣhΣi ||Fo| − |Fc||/Σ |Fo|. dRfree is Rwork for ~10% of 
the reflection that were excluded from the refinement.
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16 °C. The clarified cell lysate after lysis (50 mM Tris-HCl, pH 8.0, and 150 mM NaCl, 1 mM PMSF, Sigma) obtained 
by sonication, and sequent centrifugation, was incubated with nickel-sepharose affinity resin (GE Healthcare) 
and washed with lysis buffer. The recombinant protein was analyzed by limited proteolytic mapping, and then 
subjected to digestion with trypsin (Worthington). At first, the enzyme was dissolved in a buffer of 50 mM 
Tris-HCl at pH 8.0, and 20 mM CaCl2 to make 1 mg/ml trypsin stock solution, and aliquots were frozen at −20 °C. 
Subsequently the enzyme was added to the purified MyRF protein at a trypsin to protein (w/w) ratio of 1:500,000 
in a buffer of 50 mM Tris-HCl at pH 8.0, and 150 mM NaCl. The reaction was incubated at 4 °C for 30 minutes and 
was terminated by the addition of 10-folds excess of soybean trypsin inhibitor (Sigma) to the reaction mixture. 
The stable fragments were subsequently purified by size exclusion chromatography on a Superdex-75 column 
(GE Healthcare) pre-equilibrated in a buffer of 20 mM Tris-HCl at pH 7.4, 150 mM NaCl and 1 mM DTT. Peak 
fraction was concentrated to 20 mg/ml for crystallization.
Selenomethionine-derivatized MyRF was obtained in Escherichia coli BL21 (DE3) strain using methionine 
pathway inhibition at 289 K. The procedure for protein expression was similar to the native protein except for 
the cell culture that was performed in M9 medium containing 0.4% glucose, 2 mM magnesium sulfate, 0.1 mM 
calcium chloride, and 50 µg/l kanamycin. Cells were cultured to an OD600 of 0.8, and before adding IPTG, 
selenomethionine was supplemented along with leucine, isoleucine, and valine to the final concentration of 
50 µg/L, and lysine, threonine, and phenylalanine to 100 µg/L.
The trimer formation was checked by size exclusion chromatography on a Superdex-200 column (GE 
Healthcare) pre-equilibrated in a buffer with 20 mM Tris-HCl at pH 7.4, 50 mM NaCl and 5% glycerol.
Crystallization and Data collection. The purified proteins were crystallized by sitting drop vapor diffu-
sion method mixed 1:1 with reservoir solution. Crystals appeared in reservoir buffer containing 0.1 M Tris-HCl, 
pH 8.5, 50 mM magnesium acetate and 20% PEG4000 in 2 weeks at 18 °C. The crystals were frozen in a cryopro-
tectant consisting of the reservoir solution supplemented with 20% glycerol. Data were collected on the BL17U1 
station of the Shanghai Synchrotron Radiation Facility (SSRF)26 and then were processed using the HKL2000, 
XDS and Xia2 software27, 28.
Structure determination, Refinement and Analysis. One dataset for the selenomethionyl substituted 
MyRF DBD crystal was collected at the Se peak wavelength. The Se sites (4 sites, 4 Se per molecule) were iden-
tified using single anomalous diffraction from Se-Met by program Phenix.autosol. The model was built using 
Phenix.autobuild. The crystallographic refinement was performed by using all data to 2.46 Å resolution in COOT 
and PHENIX refinement programs29, 30. The orientations of the amino acid side chains and bound water mol-
ecules were modeled on the basis of 2Fobs_Fcalc and Fobs_Fcalc difference Fourier maps. Detailed data collection 
and refinement statistics are listed in Table 1. The model figures were generated with PyMol and CCP4mg. The 
interactions were analyzed with PyMol and LigPlus31.
The procedures used for generating the MyRF-DNA complex model. Superposition of MyRF DBD 
and Ndt80 (PDB code: 1mnn) was performed using UCSF Chimera program32 with the selection of best-aligning 
pair of chains between reference and match structure on MatchMaker. The DNA molecule in the Ndt80 structure 
was included in the superposition and modeled to the MyRF DBD. The trimeric MyRF-DNA complex was gen-
erated by symmetry operation of the single molecule.
References
 1. Emery, B. et al. Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination. Cell 138, 172–185, 
doi:10.1016/j.cell.2009.04.031 (2009).
 2. Compston, A. & Coles, A. Multiple sclerosis. Lancet 372, 1502–1517, doi:10.1016/S0140-6736(08)61620-7 (2008).
 3. Aubourg, P. The leukodystrophies: a window to myelin. Nature genetics 5, 105–106, doi:10.1038/ng1093-105 (1993).
 4. McKenzie, I. A. et al. Motor skill learning requires active central myelination. Science 346, 318–322, doi:10.1126/science.1254960 
(2014).
 5. Stohr, H., Marquardt, A., White, K. & Weber, B. H. cDNA cloning and genomic structure of a novel gene (C11orf9) localized to 
chromosome 11q12– > q13.1 which encodes a highly conserved, potential membrane-associated protein. Cytogenetics and cell 
genetics 88, 211–216, doi:15552 (2000).
 6. Li, Z., Park, Y. & Marcotte, E. M. A Bacteriophage tailspike domain promotes self-cleavage of a human membrane-bound 
transcription factor, the myelin regulatory factor MYRF. PLoS biology 11, e1001624, doi:10.1371/journal.pbio.1001624 (2013).
 7. Bujalka, H. et al. MYRF is a membrane-associated transcription factor that autoproteolytically cleaves to directly activate myelin 
genes. PLoS biology 11, e1001625, doi:10.1371/journal.pbio.1001625 (2013).
 8. Schulz, E. C. et al. Crystal structure of an intramolecular chaperone mediating triple-beta-helix folding. Nature structural & 
molecular biology 17, 210–215, doi:10.1038/nsmb.1746 (2010).
 9. Senoo, H., Araki, T., Fukuzawa, M. & Williams, J. G. A new kind of membrane-tethered eukaryotic transcription factor that shares 
an auto-proteolytic processing mechanism with bacteriophage tail-spike proteins. Journal of cell science 126, 5247–5258, 
doi:10.1242/jcs.133231 (2013).
 10. Lamoureux, J. S., Stuart, D., Tsang, R., Wu, C. & Glover, J. N. Structure of the sporulation-specific transcription factor Ndt80 bound 
to DNA. The EMBO journal 21, 5721–5732 (2002).
 11. Li, H. & Richardson, W. D. Evolution of the CNS myelin gene regulatory program. Brain research, doi:10.1016/j.brainres.2015.10.013 
(2015).
 12. Hornig, J. et al. The transcription factors Sox10 and Myrf define an essential regulatory network module in differentiating 
oligodendrocytes. PLoS genetics 9, e1003907, doi:10.1371/journal.pgen.1003907 (2013).
 13. Bork, P., Holm, L. & Sander, C. The immunoglobulin fold. Structural classification, sequence patterns and common core. Journal of 
molecular biology 242, 309–320, doi:10.1006/jmbi.1994.1582 (1994).
 14. Holm, L. & Rosenstrom, P. Dali server: conservation mapping in 3D. Nucleic acids research 38, W545–549, doi:10.1093/nar/gkq366 
(2010).
 15. Petty, T. J. et al. An induced fit mechanism regulates p53 DNA binding kinetics to confer sequence specificity. The EMBO journal 30, 
2167–2176, doi:10.1038/emboj.2011.127 (2011).
www.nature.com/scientificreports/
9Scientific RepoRts | 7: 3696  | DOI:10.1038/s41598-017-03768-9
 16. Huyen, Y. et al. Structural differences in the DNA binding domains of human p53 and its C. elegans ortholog Cep-1. Structure 12, 
1237–1243, doi:10.1016/j.str.2004.05.007 (2004).
 17. Becker, S., Groner, B. & Muller, C. W. Three-dimensional structure of the Stat3beta homodimer bound to DNA. Nature 394, 
145–151, doi:10.1038/28101 (1998).
 18. Shrivastava, T. et al. Structural basis of Ets1 activation by Runx1. Leukemia 28, 2040–2048, doi:10.1038/leu.2014.111 (2014).
 19. Friedland, N., Liou, H. L., Lobel, P. & Stock, A. M. Structure of a cholesterol-binding protein deficient in Niemann-Pick type C2 
disease. Proceedings of the National Academy of Sciences of the United States of America 100, 2512–2517, doi:10.1073/
pnas.0437840100 (2003).
 20. Li, X., Saha, P., Li, J., Blobel, G. & Pfeffer, S. R. Clues to the mechanism of cholesterol transfer from the structure of NPC1 middle 
lumenal domain bound to NPC2. Proceedings of the National Academy of Sciences of the United States of America 113, 10079–10084, 
doi:10.1073/pnas.1611956113 (2016).
 21. Mann, E., Mallette, E., Clarke, B. R., Kimber, M. S. & Whitfield, C. The Klebsiella pneumoniae O12 ATP-binding Cassette (ABC) 
Transporter Recognizes the Terminal Residue of Its O-antigen Polysaccharide Substrate. The Journal of biological chemistry 291, 
9748–9761, doi:10.1074/jbc.M116.719344 (2016).
 22. Ishikawa, K. et al. Crystal structure of beta-galactosidase from Bacillus circulans ATCC 31382 (BgaD) and the construction of the 
thermophilic mutants. The FEBS journal 282, 2540–2552, doi:10.1111/febs.13298 (2015).
 23. Senoo, H., Wang, H. Y., Araki, T., Williams, J. G. & Fukuzawa, M. An orthologue of the Myelin-gene Regulatory Transcription Factor 
regulates Dictyostelium prestalk differentiation. The International journal of developmental biology 56, 325–332, doi:10.1387/
ijdb.120030jw (2012).
 24. Neudegger, T., Verghese, J., Hayer-Hartl, M., Hartl, F. U. & Bracher, A. Structure of human heat-shock transcription factor 1 in 
complex with DNA. Nature structural & molecular biology 23, 140–146, doi:10.1038/nsmb.3149 (2016).
 25. Cherney, L. T., Cherney, M. M., Garen, C. R. & James, M. N. The structure of the arginine repressor from Mycobacterium 
tuberculosis bound with its DNA operator and Co-repressor, L-arginine. Journal of molecular biology 388, 85–97, doi:10.1016/j.
jmb.2009.02.053 (2009).
 26. Wang, Q. S. et al. The macromolecular crystallography beamline of SSRF. Nucl. Sci. Tech. 26, 12–17 (2015).
 27. Otwinowski, Z. & Minor, W. Processing of X-ray Diffraction Data Collected in Oscillation Mode. Methods in enzymology 276, 
307–326 C.W. Carter, Jr. & R. M. Sweet, Eds Academic Press (New York) (1997).
 28. Kabsch, W. X. Acta crystallographica. Section D, Biological crystallography 66, 125–132, doi:10.1107/S0907444909047337 (2010).
 29. Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta crystallographica. 
Section D, Biological crystallography 66, 213-221, 10.1107/S0907444909052925 (2010).
 30. Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta crystallographica. Section D, Biological 
crystallography 66, 486–501, doi:10.1107/S0907444910007493 (2010).
 31. Wallace, A. C., Laskowski, R. A. & Thornton, J. M. LIGPLOT: a program to generate schematic diagrams of protein-ligand 
interactions. Protein engineering 8, 127–134 (1995).
 32. Pettersen, E. F. et al. UCSF Chimera–a visualization system for exploratory research and analysis. Journal of computational chemistry 
25, 1605–1612, doi:10.1002/jcc.20084 (2004).
Acknowledgements
We are grateful to the staff at the beamline BL17U1 of the Shanghai Synchrotron Radiation Facility for excellent 
technical assistance during data collection. This work was supported by the National Natural Science Foundation 
of China (Grants 31370738) and Hundreds Talents Program of the Chinese Academy of Sciences. The work in 
H.L’s lab was supported by the Biotechnology and Biological Sciences Research Council (BB/L003236/1) and a 
Newton Advanced fellowship.
Author Contributions
X.Z., F.H. and S.Y. performed protein purification, crystallization, and biochemical experiments; B.L. generated 
the constructs; N.S. performed structure determination, structure refinement and wrote the paper; X.Z. and 
N.S. analyzed the data, designed the experiments. G.M. and H.L. discussed the results and revised the paper. All 
authors commented on the manuscript.
Additional Information
Competing Interests: The authors declare that they have no competing interests.
Accession codes: Atomic coordinates and structure factors for the reported crystal structures have been 
deposited in the Protein Data Bank with accession code 5H5P.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2017
